Effectiveness of Psychological Therapy for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-Analysis
Abstract
1. Introduction
2. Methods
2.1. Search Strategy
2.2. Study Eligibility
2.3. Data Extraction
2.4. Statistical Analysis
3. Results
3.1. Description of Studies Included
3.2. Effects of Psychological Interventions
3.3. Effects of Psychological Interventions by Type of Intervention
3.3.1. Mindfulness-Based Cognitive Therapy
3.3.2. Cognitive Behavioral Therapy
3.3.3. Cognitive Therapy
3.3.4. Long-Term Psychoanalytic Psychotherapy
3.3.5. Group Compassion-Focused Therapy
3.3.6. Trauma-Focused Cognitive Behavioral Therapy
3.3.7. Group-Based Interpersonal Psychotherapy and Occupational Therapy
3.3.8. Body-Oriented Psychological Therapy
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Gutiérrez-Rojas, L.; Porras-Segovia, A.; Dunne, H.; Andrade-González, N.; Cervilla, J.A. Prevalence and correlates of major depressive disorder: A systematic review. Braz. J. Psychiatry 2020, 42, 657–672. [Google Scholar] [CrossRef]
- Moreno-Agostino, D.; Wu, Y.-T.; Daskalopoulou, C.; Hasan, M.T.; Huisman, M.; Prina, M. Global trends in the prevalence and incidence of depression: A systematic review and meta-analysis. J. Affect. Disord. 2021, 281, 235–243. [Google Scholar] [CrossRef]
- Marx, W.; Penninx, B.W.; Solmi, M.; Furukawa, T.A.; Firth, J.; Carvalho, A.F.; Berk, M. Major depressive disorder. Nat. Rev. Dis. Primers 2023, 9, 44. [Google Scholar] [CrossRef]
- Word Health Organization. Depressive Disorder. 2023. Available online: https://www.who.int/news-room/fact-sheets/detail/depression (accessed on 1 May 2025).
- Chokka, P.; Bender, A.; Brennan, S.; Ahmed, G.; Corbière, M.; Dozois, D.J.; Habert, J.; Harrison, J.; Katzman, M.A.; McIntyre, R.S. Practical pathway for the management of depression in the workplace: A Canadian perspective. Front. Psychiatry 2023, 14, 1207653. [Google Scholar] [CrossRef]
- Arnaud, A.M.; Brister, T.S.; Duckworth, K.; Foxworth, P.; Fulwider, T.; Suthoff, E.D.; Werneburg, B.; Aleksanderek, I.; Reinhart, M.L. Impact of major depressive disorder on comorbidities: A systematic literature review. J. Clin. Psychiatry 2022, 83, 43390. [Google Scholar] [CrossRef]
- Dong, M.; Zeng, L.-N.; Lu, L.; Li, X.-H.; Ungvari, G.S.; Ng, C.H.; Chow, I.H.; Zhang, L.; Zhou, Y.; Xiang, Y.-T. Prevalence of suicide attempt in individuals with major depressive disorder: A meta-analysis of observational surveys. Psychol. Med. 2019, 49, 1691–1704. [Google Scholar] [CrossRef]
- Chesney, E.; Goodwin, G.M.; Fazel, S. Risks of all-cause and suicide mortality in mental disorders: A meta-review. World Psychiatry 2014, 13, 153–160. [Google Scholar] [CrossRef]
- Greenberg, P.; Chitnis, A.; Louie, D.; Suthoff, E.; Chen, S.Y.; Maitland, J.; Gagnon-Sanschagrin, P.; Fournier, A.A.; Kessler, R.C. The Economic Burden of Adults with Major Depressive Disorder in the United States (2019). Adv. Ther. 2023, 40, 4460–4479. [Google Scholar] [CrossRef]
- Friedrich, M.J. Depression is the leading cause of disability around the world. JAMA 2017, 317, 1517. [Google Scholar] [CrossRef]
- American Psychological Association. APA Clinical Pratice Guideline for the Treatment of Depression Across Three Age Cohorts; American Psychological Association: Washington, DC, USA, 2019. [Google Scholar]
- National Institute for Health and Care Excellence. Depression in Adults: Treatment and Management; National Institute for Health and Care Excellence: London, UK, 2022. [Google Scholar]
- Zhdanava, M.; Pilon, D.; Ghelerter, I.; Chow, W.; Joshi, K.; Lefebvre, P.; Sheehan, J.J. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J. Clin. Psychiatry 2021, 82, 29169. [Google Scholar] [CrossRef]
- Li, C.-T. Overview of treatment-resistant depression. Prog. Brain Res. 2023, 278, 1–23. [Google Scholar]
- McIntyre, R.S.; Alsuwaidan, M.; Baune, B.T.; Berk, M.; Demyttenaere, K.; Goldberg, J.F.; Gorwood, P.; Ho, R.; Kasper, S.; Kennedy, S.H. Treatment-resistant depression: Definition, prevalence, detection, management, and investigational interventions. World Psychiatry 2023, 22, 394–412. [Google Scholar] [CrossRef]
- Lex, H.; Ginsburg, Y.; Sitzmann, A.F.; Grayhack, C.; Maixner, D.F.; Mickey, B.J. Quality of life across domains among individuals with treatment-resistant depression. J. Affect. Disord. 2019, 243, 401–407. [Google Scholar] [CrossRef]
- Petersen, T.; Papakostas, G.I.; Mahal, Y.; Guyker, W.M.; Beaumont, E.C.; Alpert, J.E.; Fava, M.; Nierenberg, A.A. Psychosocial functioning in patients with treatment resistant depression. Eur. Psychiatry 2004, 19, 196–201. [Google Scholar] [CrossRef]
- Bergfeld, I.O.; Mantione, M.; Figee, M.; Schuurman, P.R.; Lok, A.; Denys, D. Treatment-resistant depression and suicidality. J. Affect. Disord. 2018, 235, 362–367. [Google Scholar] [CrossRef]
- Reutfors, J.; Andersson, T.M.-L.; Tanskanen, A.; DiBernardo, A.; Li, G.; Brandt, L.; Brenner, P. Risk factors for suicide and suicide attempts among patients with treatment-resistant depression: Nested case-control study. Arch. Suicide Res. 2021, 25, 424–438. [Google Scholar] [CrossRef]
- Szukis, H.; Joshi, K.; Huang, A.; Amos, T.B.; Wang, L.; Benson, C.J. Economic burden of treatment-resistant depression among veterans in the United States. Curr. Med. Res. Opin. 2021, 37, 1393–1401. [Google Scholar] [CrossRef]
- Crown, W.H.; Finkelstein, S.; Berndt, E.R.; Ling, D.; Poret, A.W.; Rush, A.J.; Russell, J.M. The impact of treatment-resistant depression on health care utilization and costs. J. Clin. Psychiatry 2002, 63, 963–971. [Google Scholar] [CrossRef]
- Johnston, K.M.; Powell, L.C.; Anderson, I.M.; Szabo, S.; Cline, S. The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature. J. Affect. Disord. 2019, 242, 195–210. [Google Scholar] [CrossRef]
- American Psychiatric Publishing. Clinical Practice Guideline for the Treatment of Depression. 2025. Available online: https://www.apa.org/depression-guideline/adults (accessed on 1 May 2025).
- Gabriel, F.C.; Stein, A.T.; Melo, D.O.; Fontes-Mota, G.C.H.; Dos Santos, I.B.; Rodrigues, C.D.S.; Dourado, A.; Rodrigues, M.C.; Fráguas, R.; Florez, I.D.; et al. Guidelines’ recommendations for the treatment-resistant depression: A systematic review of their quality. PLoS ONE 2023, 18, e0281501. [Google Scholar] [CrossRef]
- Lam, R.W.; Kennedy, S.H.; Adams, C.; Bahji, A.; Beaulieu, S.; Bhat, V.; Blier, P.; Blumberger, D.M.; Brietzke, E.; Chakrabarty, T. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l’humeur et de l’anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Can. J. Psychiatry 2024, 69, 641–687. [Google Scholar]
- Cuijpers, P.; Karyotaki, E.; Eckshtain, D.; Ng, M.Y.; Corteselli, K.A.; Noma, H.; Quero, S.; Weisz, J.R. Psychotherapy for depression across different age groups: A systematic review and meta-analysis. JAMA Psychiatry 2020, 77, 694–702. [Google Scholar] [CrossRef]
- Cuijpers, P. Four decades of outcome research on psychotherapies for adult depression: An overview of a series of meta-analyses. Can. Psychol./Psychol. Can. 2017, 58, 7. [Google Scholar] [CrossRef]
- Carter, B.; Strawbridge, R.; Husain, M.I.; Jones, B.D.; Short, R.; Cleare, A.J.; Tsapekos, D.; Patrick, F.; Marwood, L.; Taylor, R.W. Relative effectiveness of augmentation treatments for treatment-resistant depression: A systematic review and network meta-analysis. Int. Rev. Psychiatry 2020, 32, 477–490. [Google Scholar] [CrossRef]
- Strawbridge, R.; Carter, B.; Marwood, L.; Bandelow, B.; Tsapekos, D.; Nikolova, V.L.; Taylor, R.; Mantingh, T.; De Angel, V.; Patrick, F. Augmentation therapies for treatment-resistant depression: Systematic review and meta-analysis. Br. J. Psychiatry 2019, 214, 42–51. [Google Scholar] [CrossRef]
- Olfson, M.; Blanco, C.; Marcus, S.C. Treatment of adult depression in the United States. JAMA Intern. Med. 2016, 176, 1482–1491. [Google Scholar] [CrossRef]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
- Guyatt, G.H.; Oxman, A.D.; Vist, G.; Kunz, R.; Brozek, J.; Alonso-Coello, P.; Montori, V.; Akl, E.A.; Djulbegovic, B.; Falck-Ytter, Y. GRADE guidelines: 4. Rating the quality of evidence—Study limitations (risk of bias). J. Clin. Epidemiol. 2011, 64, 407–415. [Google Scholar] [CrossRef]
- Guyatt, G.H.; Oxman, A.D.; Montori, V.; Vist, G.; Kunz, R.; Brozek, J.; Alonso-Coello, P.; Djulbegovic, B.; Atkins, D.; Falck-Ytter, Y. GRADE guidelines: 5. Rating the quality of evidence—Publication bias. J. Clin. Epidemiol. 2011, 64, 1277–1282. [Google Scholar] [CrossRef]
- Balshem, H.; Helfand, M.; Schünemann, H.J.; Oxman, A.D.; Kunz, R.; Brozek, J.; Vist, G.E.; Falck-Ytter, Y.; Meerpohl, J.; Norris, S. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 2011, 64, 401–406. [Google Scholar] [CrossRef]
- Alserihi, A.R.; Hubayni, W.A.; Alotaibi, S.H.; Bahkali, S.; Alqurashi, S.; Abualola, M.S.; Alsaleh, A.M. Effect of cognitive remediation therapy in anorexia nervosa: A systematic review and meta-analysis. Front. Psychiatry 2024, 15, 1484457. [Google Scholar] [CrossRef]
- Dellazizzo, L.; Potvin, S.; Giguère, S.; Landry, C.; Léveillé, N.; Dumais, A. Meta-review on the efficacy of psychological therapies for the treatment of substance use disorders. Psychiatry Res. 2023, 326, 115318. [Google Scholar] [CrossRef]
- Hu, Y.; Yuan, X.; Ye, P.; Chang, C.; Hu, Y.H.; Zhang, W.; Li, K. Virtual reality in clinical nursing practice over the past 10 years: Umbrella review of meta-analyses. JMIR Serious Games 2023, 11, e52022. [Google Scholar] [CrossRef]
- Guyatt, G.; Oxman, A.D.; Akl, E.A.; Kunz, R.; Vist, G.; Brozek, J.; Norris, S.; Falck-Ytter, Y.; Glasziou, P.; DeBeer, H.; et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J. Clin. Epidemiol. 2011, 64, 383–394. [Google Scholar] [CrossRef]
- Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 2010, 36, 1–48. [Google Scholar] [CrossRef]
- Cooper, H.; Hedges, L.V.; Valentine, J.C. The Handbook of Research Synthesis and Meta-Analysis; Russell Sage Foundation: New York, NY, USA, 2019. [Google Scholar]
- Andrade, C. Mean difference, standardized mean difference (SMD), and their use in meta-analysis: As simple as it gets. J. Clin. Psychiatry 2020, 81, 11349. [Google Scholar] [CrossRef]
- Cuijpers, P.; Li, J.; Hofmann, S.G.; Andersson, G. Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: A meta-analysis. Clin. Psychol. Rev. 2010, 30, 768–778. [Google Scholar] [CrossRef]
- Higgins, J.P.; Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21, 1539–1558. [Google Scholar] [CrossRef]
- Dragioti, E.; Karathanos, V.; Gerdle, B.; Evangelou, E. Does psychotherapy work? An umbrella review of meta-analyses of randomized controlled trials. Acta Psychiatr. Scand. 2017, 136, 236–246. [Google Scholar] [CrossRef]
- Bhattacharya, S.; Kennedy, M.; Miguel, C.; Tröger, A.; Hofmann, S.G.; Cuijpers, P. Effect of psychotherapy for adult depression on self-esteem: A systematic review and meta-analysis. J. Affect. Disord. 2023, 325, 572–581. [Google Scholar] [CrossRef]
- Egger, M.; Smith, G.D.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315, 629–634. [Google Scholar] [CrossRef]
- Foroughi, A.; Sadeghi, K.; Parvizifard, A.; Parsa Moghadam, A.; Davarinejad, O.; Farnia, V.; Azar, G. The effectiveness of mindfulness-based cognitive therapy for reducing rumination and improving mindfulness and self-compassion in patients with treatment-resistant depression. Trends Psychiatry Psychother. 2020, 42, 138–146. [Google Scholar] [CrossRef]
- Cladder-Micus, M.B.; Speckens, A.E.; Vrijsen, J.N.; Donders, A.R.T.; Becker, E.S.; Spijker, J. Mindfulness-based cognitive therapy for patients with chronic, treatment-resistant depression: A pragmatic randomized controlled trial. Depress. Anxiety 2018, 35, 914–924. [Google Scholar] [CrossRef]
- Eisendrath, S.J.; Gillung, E.; Delucchi, K.L.; Segal, Z.V.; Nelson, J.C.; McInnes, L.A.; Mathalon, D.H.; Feldman, M.D. A randomized controlled trial of mindfulness-based cognitive therapy for treatment-resistant depression. Psychother. Psychosom. 2016, 85, 99–110. [Google Scholar] [CrossRef]
- Hauksson, P.; Ingibergsdóttir, S.; Gunnarsdóttir, T.; Jónsdóttir, I.H. Effectiveness of cognitive behaviour therapy for treatment-resistant depression with psychiatric comorbidity: Comparison of individual versus group CBT in an interdisciplinary rehabilitation setting. Nord. J. Psychiatry 2017, 71, 465–472. [Google Scholar] [CrossRef]
- Wilkinson, S.T.; Rhee, T.G.; Joormann, J.; Webler, R.; Ortiz Lopez, M.; Kitay, B.; Fasula, M.; Elder, C.; Fenton, L.; Sanacora, G. Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: A randomized clinical trial. Psychother. Psychosom. 2021, 90, 318–327. [Google Scholar] [CrossRef]
- Leykin, Y.; Amsterdam, J.D.; DeRubeis, R.J.; Gallop, R.; Shelton, R.C.; Hollon, S.D. Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. J. Consult. Clin. Psychol. 2007, 75, 267. [Google Scholar] [CrossRef]
- Harpin, R.E.; Liberman, R.P.; Marks, I.; Stern, R.; Bohannon, W.E. Cognitive-Behavior Therapy for Chronically Depressed Patients A Controlled Pilot Study. J. Nerv. Ment. Dis. 1982, 170, 295–301. [Google Scholar] [CrossRef]
- Fonagy, P.; Rost, F.; Carlyle, J.A.; McPherson, S.; Thomas, R.; Pasco Fearon, R.; Goldberg, D.; Taylor, D. Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: The Tavistock Adult Depression Study (TADS). World Psychiatry 2015, 14, 312–321. [Google Scholar] [CrossRef]
- Asano, K.; Tsuchiya, M.; Okamoto, Y.; Ohtani, T.; Sensui, T.; Masuyama, A.; Isato, A.; Shoji, M.; Shiraishi, T.; Shimizu, E. Benefits of group compassion-focused therapy for treatment-resistant depression: A pilot randomized controlled trial. Front. Psychol. 2022, 13, 903842. [Google Scholar] [CrossRef]
- Minelli, A.; Zampieri, E.; Sacco, C.; Bazzanella, R.; Mezzetti, N.; Tessari, E.; Barlati, S.; Bortolomasi, M. Clinical efficacy of trauma-focused psychotherapies in treatment-resistant depression (TRD) in-patients: A randomized, controlled pilot-study. Psychiatry Res. 2019, 273, 567–574. [Google Scholar] [CrossRef]
- Röhricht, F.; Papadopoulos, N.; Priebe, S. An exploratory randomized controlled trial of body psychotherapy for patients with chronic depression. J. Affect. Disord. 2013, 151, 85–91. [Google Scholar] [CrossRef]
- Murray, G.; Michalak, E.E.; Axler, A.; Yaxley, D.; Hayashi, B.; Westrin, Å.; Ogrodniczuk, J.S.; Tam, E.M.; Yatham, L.N.; Lam, R.W. Relief of chronic or resistant depression (Re-ChORD): A pragmatic, randomized, open-treatment trial of an integrative program intervention for chronic depression. J. Affect. Disord. 2010, 123, 243–248. [Google Scholar] [CrossRef]
- Cuijpers, P.; Turner, E.H.; Koole, S.L.; Van Dijke, A.; Smit, F. What is the threshold for a clinically relevant effect? The case of major depressive disorders. Depress. Anxiety 2014, 31, 374–378. [Google Scholar] [CrossRef]
- Hengartner, M.P.; Plöderl, M. Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter! Front. Psychiatry 2018, 9, 517. [Google Scholar] [CrossRef]
- Cuijpers, P.; Karyotaki, E.; Ciharova, M.; Miguel, C.; Noma, H.; Furukawa, T.A. The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta-analysis. Acta Psychiatr. Scand. 2021, 144, 288–299. [Google Scholar] [CrossRef]
- Cuijpers, P.; Karyotaki, E.; Reijnders, M.; Purgato, M.; Barbui, C. Psychotherapies for depression in low-and middle-income countries: A meta-analysis. World Psychiatry 2018, 17, 90–101. [Google Scholar] [CrossRef]
- Cuijpers, P.; van Straten, A.; Bohlmeijer, E.; Hollon, S.D.; Andersson, G. The effects of psychotherapy for adult depression are overestimated: A meta-analysis of study quality and effect size. Psychol. Med. 2010, 40, 211–223. [Google Scholar] [CrossRef]
- Cuijpers, P.; Miguel, C.; Ciharova, M.; Harrer, M.; Moir, F.; Roskvist, R.; van Straten, A.; Karyotaki, E.; Arroll, B. Psychological treatment of adult depression in primary care compared with outpatient mental health care: A meta-analysis. J. Affect. Disord. 2023, 339, 660–675. [Google Scholar] [CrossRef]
- Bristow, K.; Patten, S. Treatment-seeking rates and associated mediating factors among individuals with depression. Can. J. Psychiatry 2002, 47, 660–665. [Google Scholar] [CrossRef]
- Marcus, S.M.; Kerber, K.B.; Rush, A.J.; Wisniewski, S.R.; Nierenberg, A.; Balasubramani, G.; Ritz, L.; Kornstein, S.; Young, E.A.; Trivedi, M.H. Sex differences in depression symptoms in treatment-seeking adults: Confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr. Psychiatry 2008, 49, 238–246. [Google Scholar] [CrossRef]
- Kuehner, C. Why is depression more common among women than among men? Lancet Psychiatry 2017, 4, 146–158. [Google Scholar] [CrossRef]
- Cuijpers, P.; Van Straten, A.; Warmerdam, L.; Smits, N. Characteristics of effective psychological treatments of depression: A metaregression analysis. Psychother. Res. 2008, 18, 225–236. [Google Scholar] [CrossRef]
- Cuijpers, P.; Weitz, E.; Twisk, J.; Kuehner, C.; Cristea, I.; David, D.; DeRubeis, R.J.; Dimidjian, S.; Dunlop, B.W.; Faramarzi, M. Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: An “individual patient data” meta-analysis. Depress. Anxiety 2014, 31, 941–951. [Google Scholar] [CrossRef]
- Cuijpers, P.; Miguel, C.; Ciharova, M.; Quero, S.; Plessen, C.Y.; Ebert, D.; Harrer, M.; van Straten, A.; Karyotaki, E. Psychological treatment of depression with other comorbid mental disorders: Systematic review and meta-analysis. Cogn. Behav. Ther. 2023, 52, 246–268. [Google Scholar] [CrossRef]
- Kessler, R.C.; Sampson, N.A.; Berglund, P.; Gruber, M.J.; Al-Hamzawi, A.; Andrade, L.; Bunting, B.; Demyttenaere, K.; Florescu, S.; De Girolamo, G. Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys. Epidemiol. Psychiatr. Sci. 2015, 24, 210–226. [Google Scholar] [CrossRef]
- Fava, M.; Farabaugh, A.; Sickinger, A.; Wright, E.; Alpert, J.; Sonawalla, S.; Nierenberg, A.; Worthington Iii, J. Personality disorders and depression. Psychol. Med. 2002, 32, 1049–1057. [Google Scholar] [CrossRef]
- Saha, S.; Lim, C.C.; Degenhardt, L.; Cannon, D.L.; Bremner, M.; Prentis, F.; Lawrence, Z.; Heffernan, E.; Meurk, C.; Reilly, J. Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis. Aust. N. Z. J. Psychiatry 2022, 56, 757–770. [Google Scholar] [CrossRef]
- Oliveira-Maia, A.J.; Bobrowska, A.; Constant, E.; Ito, T.; Kambarov, Y.; Luedke, H.; Mulhern-Haughey, S.; von Holt, C. Treatment-resistant depression in real-world clinical practice: A systematic literature review of data from 2012 to 2022. Adv. Ther. 2024, 41, 34–64. [Google Scholar] [CrossRef]
- DiBello, J.R.; Xiong, X.; Liu, X.; Zhong, W.; Merola, A.; Li, M.; Lu, Z.K. Trajectories of pharmacological therapies for treatment-resistant depression: A longitudinal study. BMC Psychiatry 2025, 25, 215. [Google Scholar] [CrossRef]
- Zhong, B. How to calculate sample size in randomized controlled trial? J. Thorac. Dis. 2009, 1, 51–54. [Google Scholar] [PubMed]
- Sado, M.; Koreki, A.; Ninomiya, A.; Kurata, C.; Mitsuda, D.; Sato, Y.; Kikuchi, T.; Fujisawa, D.; Ono, Y.; Mimura, M. Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings. Psychiatry Clin. Neurosci. 2021, 75, 341–350. [Google Scholar] [CrossRef] [PubMed]
- Wiles, N.J.; Thomas, L.; Turner, N.; Garfield, K.; Kounali, D.; Campbell, J.; Kessler, D.; Kuyken, W.; Lewis, G.; Morrison, J. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: Follow-up of the CoBalT randomised controlled trial. Lancet Psychiatry 2016, 3, 137–144. [Google Scholar] [CrossRef] [PubMed]
- Koeser, L.; Rost, F.; Gabrio, A.; Booker, T.; Taylor, D.; Fonagy, P.; Goldberg, D.; Knapp, M.; McCrone, P. Cost-effectiveness of long-term psychoanalytic psychotherapy for treatment-resistant depression: RCT evidence from the Tavistock Adult Depression Study (TADS). J. Affect. Disord. 2023, 335, 313–321. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Giguère, S.; Fortier, A.; Azrak, J.; Giguère, C.-É.; Potvin, S.; Dumais, A. Effectiveness of Psychological Therapy for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-Analysis. J. Pers. Med. 2025, 15, 338. https://doi.org/10.3390/jpm15080338
Giguère S, Fortier A, Azrak J, Giguère C-É, Potvin S, Dumais A. Effectiveness of Psychological Therapy for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 2025; 15(8):338. https://doi.org/10.3390/jpm15080338
Chicago/Turabian StyleGiguère, Sabrina, Alexandra Fortier, Julie Azrak, Charles-Édouard Giguère, Stéphane Potvin, and Alexandre Dumais. 2025. "Effectiveness of Psychological Therapy for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-Analysis" Journal of Personalized Medicine 15, no. 8: 338. https://doi.org/10.3390/jpm15080338
APA StyleGiguère, S., Fortier, A., Azrak, J., Giguère, C.-É., Potvin, S., & Dumais, A. (2025). Effectiveness of Psychological Therapy for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine, 15(8), 338. https://doi.org/10.3390/jpm15080338